Skip to main navigation
Skip to search
Skip to main content
New Jersey Institute of Technology Home
Help & FAQ
Home
Profiles
Research units
Facilities
Federal Grants
Research output
Press/Media
Search by expertise, name or affiliation
Treatment of hind limb ischemia using angiogenic peptide nanofibers
Vivek A. Kumar
, Qi Liu
, Navindee C. Wickremasinghe
, Siyu Shi
, Toya T. Cornwright
, Yuxiao Deng
, Alon Azares
, Amanda N. Moore
, Amanda M. Acevedo-Jake
, Noel R. Agudo
, Su Pan
, Darren G. Woodside
, Peter Vanderslice
, James T. Willerson
, Richard A. Dixon
, Jeffrey D. Hartgerink
Research output
:
Contribution to journal
›
Article
›
peer-review
102
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of hind limb ischemia using angiogenic peptide nanofibers'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Aged Mice
50%
Angiogenesis
50%
Angiogenic Peptides
100%
Biodistribution Studies
50%
Cell Transplantation
50%
Clinical Efficacy
50%
Clinical Translation
50%
Clinical Trials
50%
Days of Treatment
50%
Endurance Test
50%
FDA-approved Drugs
50%
Gene Therapy
50%
Gene Transfection
50%
Growth Factors
50%
Healthy Mice
50%
Hindlimb Ischemia
100%
Host Cell
50%
Injectable Hydrogel
50%
Intramuscularly
50%
Ischemic Tissue
100%
Limb Perfusion
50%
Microvascular Perfusion
50%
Nanofibrous
50%
Neovessel
50%
Peptide Nanofibers
100%
Peptide Scaffold
50%
Peptide-based
100%
Peripheral Arterial Disease
50%
Proangiogenic Therapy
50%
Regenerative Medicine
50%
Reperfusion
50%
Revascularization
50%
Stem Cell Therapy
50%
Synthetic Peptides
50%
Thixotropic
50%
Tissue Recovery
50%
Treadmill
50%
Vascular Tissue Engineering
50%
Vasculature
50%
Viral Gene
50%
Medicine and Dentistry
Angiogenesis
50%
Arteriosclerosis Obliterans
50%
Biodistribution
50%
Cell Transplantation
50%
Clinical Trial
50%
Gene Therapy
50%
Growth Factor
50%
Hindlimb
100%
Host Cell
50%
Limb Ischemia
100%
Limb Perfusion
50%
Medicine
50%
Nanofiber
100%
Revascularization
50%
Stem Cell Therapy
50%
Synthetic Peptide
50%
Vascularity
50%
Vasculotropin
50%
Viral Gene Delivery System
50%
Pharmacology, Toxicology and Pharmaceutical Science
Biodistribution
33%
Clinical Trial
33%
Growth Factor
33%
Limb Ischemia
100%
Limb Perfusion
33%
Mouse
100%
Nanofiber
100%
Peripheral Occlusive Artery Disease
33%
Preclinical Study
33%
Synthetic Peptide
33%
Vasculotropin
33%
Biochemistry, Genetics and Molecular Biology
Angiogenesis
33%
Biodistribution
33%
Cell Transplantation
33%
Clinical Trial
33%
Gene Therapy
33%
Growth Factor
33%
Limb Perfusion
33%
Mouse
100%
Perfusion
33%
Preclinical Study
33%
Reperfusion
33%
Stem Cell Transplantation
33%
Vascular Endothelial Growth Factor
33%
Vascularization
33%
Viral Gene Delivery System
33%
Neuroscience
Angiogenesis
50%
Growth Factor
50%
Ischemia
100%
Stem Cell
50%
Synthetic Peptide
50%
Vascular Endothelial Growth Factor
50%
Viral Gene Delivery System
50%